Hospital de Santa Marta is a public Central Hospital serving the Greater Lisbon area as part of the Central Lisbon University Hospital Centre, a state-owned enterprise.

During the past decade, Hospital de Santa Marta conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Santa Marta" #1 sponsor was "Actelion" with 5 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Centro Hospitalar de Lisboa Central" with 2 trials sponsored, "LivaNova" with 2 trials sponsored and "MicroPort CRM" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Santa Marta" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Aix Scientifics" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "BUPA Foundation" with 1 trials as a collaborator and "Bolton Medical" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Santa Marta" are "Heart Failure" (5 trials), "Pulmonary Arterial Hypertension" (4 trials), "Coronary Artery Disease" (3 trials), "Atrial Fibrillation" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "Hospital de Santa Marta" in a lesser frequency.

Most popular intervention types in "Hospital de Santa Marta" are "Drug" (14 trials), "Device" (13 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Macitentan 10 mg" (2 trials), "Abdominal" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Santa Marta" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Santa Marta". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Hospital de Santa Marta, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Santa Marta, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".